To establish a predicting model for IDH mutation status and 1p19q codeletion in glioma patients, radiomic features were extracted from preoperative MRIs of T1 contrast enhanced and T2-FLAIR sequences [71]. Here, IDH1 is linked to central nervous system cancer.